Posted in | News | Bionanotechnology

GENEWIZ Now Offers Gene Synthesis Services for DNA Innovations in Nanotechnology

GENEWIZ, Inc., a leading provider of DNA services, announced the expansion of its molecular biology portfolio with the addition of Gene Synthesis services.

Gene synthesis provides researchers with a time- and cost-saving alternative to molecular cloning, DNA engineering, protein engineering and directed evolution for custom construct production.

GENEWIZ's expertise allows synthesizing genes of varying complexities with extremely high success rates, spanning short genes to long, 50-kb genes and difficult genes with repetitive sequences, high GC-content, or secondary structures. Institutional partnership agreements have been executed with major pharmaceutical and biotechnology companies. "We very much respect the trust that our DNA sequencing customers have placed in us, and are grateful that they have extended that trust to our gene synthesis services," stated Ping Yang, Ph.D., GENEWIZ Business Leader for Gene Synthesis. "We are proud to support our customers' DNA innovations in such important fields as biofuels, nanotechnology, protein and antibody engineering, vaccines, and gene therapy. We have experienced widespread customer adoption beyond our expectations by academic, pharmaceutical, biotechnology, and government researchers."

GENEWIZ focuses on supporting its gene synthesis customers with excellent project managers, all with deep technical expertise. The gene synthesis service offering includes competitive prices, comprehensive project management and fast turnaround times. Difficult genes require longer turnaround times; GENEWIZ has synthesized and delivered difficult genes that were refused by or failed with other service providers. All synthesized genes are sequence-verified.

Marc Schwartz, Ph.D., GENEWIZ Project Manager for gene synthesis, noted, "Outsourcing of bio-reagent construction is often favored as a cost-saving approach. Our customers benefit from our specialized expertise, 10-year track record of superior project management, and stringent quality assurance system."


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.